Triple-negative breast cancer (TNBC), a phenotypic subtype characterized by a lack of oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, is an aggressive form of breast cancer associated with a poor prognosis (4, 5). The gene discussed is PGR; the disease is breast carcinoma.